Nektar Therapeutics (ITH0.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-1.55
-1.48
-1.42
-1.35

Details

Expected EPS
-1.34921981649
Actual EPS
-1.5518594
Surprise EPS
-0.2
Surprise Percent
+15.02%

Description

Nektar Therapeutics (ITH0.STU) has reported earnings of -1.5518594 per share for Q2 2026.

0 Comments

Share your thoughts